DOCSLIB.ORG

(12) United States Patent (10) Patent No.: US 8,435,523 B2 Powell Et Al

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
(12) United States Patent (10) Patent No.: US 8,435,523 B2 Powell Et Al USOO8435523B2 (12) United States Patent (10) Patent No.: US 8,435,523 B2 POWell et al. (45) Date of Patent: May 7, 2013 (54) ANTIBODIES AGAINST NERVE GROWTH 2008, OO63635 A1 3/2008 Takahashi et al. 2008/0081040 A1 4/2008 Shelton et al. FACTOR (NGF) WITH ENHANCED IN VIVO 2008. O107658 A1 5/2008 Franks et al. STABILITY 2008. O182978 A1 7/2008 Rosenthal et al. 2008, 0213282 A1 9, 2008 Jacob et al. (75) Inventors: John Powell, Cambridgeshire (GB); 2009/004 1717 A1 2/2009 MacDonald et al. Duncan Casson, Royston (GB); Mark 2009. O155274 A1 6/2009 Wild, Jr. et al. 2009, 0208490 A1 8, 2009 Pavone et al. Maginn, Wilburton (GB); Wei Liu, 2009/0300780 A1 12/2009 Cattaneo et al. Mundelein (IL); Sandeep Dutta, Gurnee 2010.0034.818 A1 2/2010 Wild, Jr. et al. (IL); Andrea Best, Lake Forest (IL); 2010.005.5097 A1 3/2010 Kaisheva et al. Jerry A. Hall, Gurnee (IL) 2010/01 11970 A1 5, 2010 Pons et al. 2010.0143355 A1 6, 2010 Shelton et al. (73) Assignee: Abbott Research B.V. Zwolle (NL) 2010/0240582 A1 9/2010 Boone et al. 2010/026O775 A1 10/2010 Mills et al. 2010/0267934 A1 10/2010 Van De Winkel et al. (*) Notice: Subject to any disclaimer, the term of this 2011 OO14208 A1 1/2011 Macdonald et al. patent is extended or adjusted under 35 2011 OO33447 A1 2/2011 Rosenthal et al. U.S.C. 154(b) by 438 days. 2011/0091476 A1 4/2011 Wild, Jr. et al. 2011 0104164 A1 5/2011 Cattaneo et al. (21) Appl. No.: 12/773,488 2011/0105728 A1 5/2011 Cattaneo et al. 2011 019 1872 A1 8/2011 Cattaneo et al. 2011/0243961 A1 10/2011 Shelton et al. (22) Filed: May 4, 2010 2011/O256587 A1 10/2011 Macdonald et al. (65) Prior Publication Data FOREIGN PATENT DOCUMENTS US 2010/0278839 A1 Nov. 4, 2010 EP O578515 1, 1994 EP 059.2106 4f1994 EP 1891966 2, 2008 Related U.S. Application Data EP 2100902 9, 2009 (60) Provisional application No. 61/175.228, filed on May EP 219 1846 6, 2010 4, 2009, provisional application No. 61/227,251, filed (Continued) on Jul. 21, 2009, provisional application No. 61/238, OTHER PUBLICATIONS 813, filed on Sep. 1, 2009, provisional application No. Berardi et al., “Monoclonal antibodies to nerve growth factor affect 61/252,314, filed on Oct. 16, 2009. the postnatal development of the visual system.” Proc. Natl. Acad. Sci. USA,91:684-688 (1994). (51) Int. Cl. Boss et al., Immunol. Today, 6:12-13 (1985). A 6LX39/395 (2006.01) Bothwell, “p75NTR: a receptor after all.” Science, 272(5261):506 C07K 6/22 (2006.01) 507 (1996). Cattaneo et al., “Functional Blockade of Tyrosine Kinasea in the Rat (52) U.S. Cl. Basal Forebrain in a Novel Antagonistic Anti Receptor Monoclonal USPC ................... 424/145.1: 514/17.7:530/388.24 Antibody.” J. Neurosci., 19(22):9687-9697 (1999). (58) Field of Classification Search ........................ None Graziano et al., "Construction and characterization of a humanized See application file for complete search history. anti-gamma-Ig receptor type I (Fc gamma RI) monoclonal antibody.” J. Immunol., 155(10):4996-5002 (1995). (56) References Cited Harding et al., "Class Switching in human immunoglobulin transgenic mice.” Ann. NY Acad. Sci., 764:536-546 (1995). Hinton et al., “An engineered human IgG1 antibody with longer U.S. PATENT DOCUMENTS serum half-life.” J. Immunol., 176(1):346-356 (2006). 4,230,691 A 10/1980 Young Hinton et al., “Engineered human IgG antibodies with longer serum 6,017,878 A 1/2000 Saragoviet al. half-lives in primates.” J. Biol. Chem., 279 (8):6213-6216 (2004). 6,919,426 B2 7/2005 Boone et al. Morrison, “Transfectomas provide novel chimeric antibodies.” Sci 7,252,822 B2 8, 2007 Shelton et al. ence, 229(4719): 1202-1207 (1985). 7,255,860 B2 8, 2007 Shelton et al. 7,371,559 B2 5, 2008 Boone et al. (Continued) 7,425,329 B2 9, 2008 Shelton et al. 7,449,616 B2 11/2008 Pons et al. Primary Examiner — Robert C Hayes 7,569,364 B2 8, 2009 Rosenthal et al. (74) Attorney, Agent, or Firm — McAndrews, Held & 7,601,818 B2 10/2009 Wild, Jr. et al. 7,655,231 B2 2/2010 Shelton et al. Malloy, Ltd. 7,655,232 B2 2/2010 Pons et al. (57) ABSTRACT 7.727,527 B2 6, 2010 Shelton 7,795,413 B2 9/2010 Wild, Jr. et al. The present invention provides anti-nerve growth factor 7,988,967 B2 8/2011 MacDonald et al. (NGF) antibodies that contain an IgG4 constant region com 8,007,800 B2 8, 2011 Shelton et al. prising a stabilizing hinge region mutation and wherein the 2001/004.6959 A1 11/2001 Buchkovich et al. antibodies exhibit an unexpectedly long serum half life in 2004f0071701 A1 4/2004 Delafoy et al. 2004/O131615 A1 7/2004 Shelton et al. cynomolgus monkeys. Pharmaceutical compositions com 2004/0228862 A1 11/2004 Shelton et al. prising the anti-NGF antibodies, nucleic acids encoding the 2004/0237124 A1 11/2004 Pons et al. NGF antibodies, host cells for expressing the NGF antibodies 2005, OO74821 A1 4, 2005 Wild et al. and methods of using the antibodies for treating NGF-related 2006, O147450 A1 7/2006 Shelton 2007/0264195 A1 1 1/2007 Nykiaer et al. diseases or conditions are also provided. 2008.OO33157 A1 2/2008 Wild et al. 9 Claims, 7 Drawing Sheets US 8,435,523 B2 Page 2 FOREIGN PATENT DOCUMENTS Ro et al., “Effect of NGF and anti-NGF on neuropathic pain in rats EP 22O6728 T 2010 following chronic constriction injury of the Sciatic nerve.” Pain, EP 2263692 12/2010 79:265-274 (1999). EP 227OO48 1, 2011 Ruberti et al., “Phenotypic knockout of nerve growth factor in adult WO 92.09631 6, 1992 transgenic mice reveals severe deficits in basal forebrain cholinergic WO 90, 10644 9, 1999 neurons, cell death in the spleen, and skeletal muscle dystrophy.” J. WO OOf73344 12/2000 WO O1 10203 2, 2001 Neurosci., 2007):2589-2601 (2000). WO 01.64247 9, 2001 Ruberti et al., “The use of the RACE method to clone hybridoma WO O1 (78698 10, 2001 cDNA when V region primers fail.” J. Immunol. Methods, 173:33-39 WO O2/O964.58 12/2002 (1994). WO 2004/026329 4/2004 Rudikoff et al., “Single amino acid Substitution altering antigen WO 2004/032852 4/2004 binding specificity.” Proc. Natl. Acad. Sci. Usa, 79 (6):1979-1983 WO 2004/032870 4/2004 (1982). WO 2004/056385 T 2004 Saragoviet al., “Development of pharmacological agents for target WO 2004/0581.84 T 2004 ing neurotrophins and their receptors. Trends Pharmacol. Sci., WO 2004/065560 8, 2004 WO 2004/0736.53 9, 2004 21(3):93-98 (2000). WO 2005/OOO194 1, 2005 Shields et al., “High resolution mapping of the binding site on human WO 2005/O19266 3, 2005 IgG1 for Fc gamma RI. Fc gamma RII, Fc gamma RIII, and FcRn and WO 2005/044.293 5, 2005 design of IgG1 variants with improved binding to the Fc gamma R. WO 2005/061540 7/2005 J. Biol. Chem., 276 (9):6591-6604 (2001). WO 2005/061540 A2 * T 2005 Stephens et al., “Comprehensive pharmacokinetics of a humanized WO 2005,105847 11, 2005 antibody and analysis of residual anti-idiotypic responses.” Immu WO 2005,111077 11, 2005 nology, 85(4):668-674 (1995). WO 2006/077441 T 2006 Tripathy et al., “TrkAkinase inhibitors from a library of modified and WO 2006, 110883 10, 2006 isosteric Staurosporine aglycone.” Bioorg. Med. Chem. Lett. WO 2006,131951 12/2006 WO 2006,131952 12/2006 18(12):3551-3555 (2008). WO 2006,137106 12/2006 Angal et al., “A Single Amino Acid Substitution Abolishes the Het WO 2008. 145142 12/2008 erogeneity of Chimeric Mouse/Human (IgG4) Antibody.” Mol. WO 2009/023540 2, 2009 Immunol. 30(1) 105-108 (1993). WO 2009 O77993 6, 2009 Cattaneo et al., “Three Distinct Types of Monoclonal Antibodies WO 2010, 128398 11, 2010 After Long-Term Immunization of Rats with Mouse Nerve Growth WO 2011 116090 9, 2011 Factor.” J. Neurochem, 50:1003-1010 (1988). Correia, "Stability of IgG isotypes in serum.” mAbs, 2(3):1-12 OTHER PUBLICATIONS (2010). Myers et al., “Optimal alignments in linear space.” Comput. Appl. International Preliminary Report on Patentability in PCT/IB2010/ Biosci., 4(1): 11-17 (1988). 00.1210 dated Nov. 9, 2011. Needleman et al., “A general method applicable to the search for International Search Report in PCT/IB2010/001210 dated Sep. 10, similarities in the amino acid sequence of two proteins. J. Mol. Biol. 2010. 48(3):443-453 (1970). Ruberti et al., “Cloning and Expression of an Anti-Nerve Growth Petkova et al., “Enhanced half-life of genetically engineered human Factor (NGF) Antibody for Studies Using the Neuroantibody IgG1 antibodies in a humanized FeRn mouse model: potential appli Approach.” Cell. Mol. Neurobiol. 13(5):559-568 (1993). cation in humorally mediated autoimmune disease.” Itn. Immunol. 18(12): 1759-1769 (2006). * cited by examiner U.S. Patent May 7, 2013 Sheet 1 of 7 US 8,435,523 B2 torescece its : & 8 F dig Figure U.S. Patent May 7, 2013 Sheet 2 of 7 US 8,435,523 B2 % Cottro; 3isting X : & : : *: Figure 2A U.S. Patent May 7, 2013 Sheet 3 of 7 US 8,435,523 B2 % controi Biciing i Figure 28 U.S. Patent May 7, 2013 Sheet 4 of 7 US 8,435,523 B2 % controi response g Figure 3A U.S.
Load more

Recommended publications
  • Backing Material Packaging Liner
    US009314527B2 (12) United States Patent (10) Patent No.: US 9,314,527 B2 Cottrell et al. (45) Date of Patent: *Apr. 19, 2016 (54) TRANSDERMAL DELIVERY PATCH 9/7061 (2013.01); A61K 9/7084 (2013.01); (71) Applicant: Phosphagenics Limited, Clayton, A61 K3I/355 (2013.01); A61K47/24 Victoria (AU) SE7 8E.O. (72) Inventors: Jeremy Cottrell, Caulfield South (AU); ( .01): ( .01): (2013.01) Giacinto Gaetano, South Melbourne (AU); Mahmoud El-Tamimy, Meadow (58) Field of Classification Search Heights (AU); Nicholas Kennedy, None Boronia (AU); Paul David Gavin, See application file for complete search history. Chadstone (AU) (56) References Cited (73) Assignee: Phosphagenics Limited, Victoria (AU) (*) Notice: Subject to any disclaimer, the term of this U.S. PATENT DOCUMENTS patent is extended or adjusted under 35 2,407,823. A 9, 1946 Fieser U.S.C. 154(b) by 0 days. 2.457,932 A 1/1949 Solmssen et al. This patent is Subject to a terminal dis- (Continued) claimer. (21) Appl. No.: 14/550,514 FOREIGN PATENT DOCUMENTS ppl. No.: 9 (22) Filed: Nov. 21, 2014 A 3.3 5.83 (65) Prior Publication Data (Continued) Related U.S. Application Data Gianello et al. Subchronic Oral Toxicity Study of Mixed Tocopheryl (63) Continuation of application No. 14/086,738, filed on Phosphates in Rates, International Journal of Toxicology, 26:475 Nov. 21, 2013, now abandoned, which is a 490; 2007.* continuation of application No. 13/501,500, filed as (Continued) application No. PCT/AU2011/000358 on Mar. 30, 2011, now Pat. No. 8,652,511. Primary Examiner — Robert A Wax (60) Provisional application No.
    [Show full text]
  • Serial Reasonimg
    Serial reasonimg FAQS Water forms of asia map reciver i class a9a9 Serial reasonimg words with a long e sound ending in silent e Serial reasonimg Serial reasonimg Founders step chant delta sigma theta Serial reasonimg Ellipsis worksheets Global Anh khoa than ca si ho ngoc hanh khoa than ca si ho ngoc haFurthermore, though serial killers like Charles Manson were abused and neglected as TEENren, the list of serial killers with a normal TEENhood is long. Famous serial killers such as Ted Bundy. Serial Reasoning During the “Serial Reasoning” portion of the NNAT, TEENren observe a series of geometric shapes that gradually change across the row and down the columns. The desired result is that each shape will only appear once in each row and column. Serial Reasoning questions assess the test taker’s ability to supply a missing element in a given matrix comprised of geometric shapes. Each matrix is composed of nine boxes in a three-by-three grid. The test taker is to determine which answer choice belongs in the empty box in the bottom right-hand corner of the grid. The Bright TEENsTM Serial Reasoning workbook for the NNAT2 – Levels A and B can help a student become accustomed to the Serial Reasoning questions found on the NNAT2. There are 20 series exercises and 50 Serial Reasoning questions in this workbook. read more Creative Serial reasonimgvaNo valid code word in the system that is a prefix start. Hydrocodone Hydromorphinol Hydromorphone Nicocodeine Nicodicodeine Nicomorphine Oxycodone Oxymorphone Alphaprodine Anileridine Butorphanol Dextromoramide Dextropropoxyphene Dezocine Fentanyl. If we arent careful one user has the potential to take down the entire site.
    [Show full text]
  • Gastroparesis and Nutrition: the Art
    NUTRITION ISSUES IN GASTROENTEROLOGY, SERIES #99 Carol Rees Parrish, R.D., M.S., Series Editor Gastroparesis and Nutrition: The Art Carol Rees Parrish Stacey McCray Gastroparesis, or delayed gastric emptying, is a complex disorder characterized by nausea, vomiting, early satiety, and abdominal discomfort. Complications of gastro- paresis not only lead to increased morbidity, increased time spent in the hospital, and significant nutritional deficits, but also impact the overall quality of life of those affected. This article will review the anatomy and physiology of gastroparesis, discuss some of the treatment options available, and outline recommendations for nutritional monitoring and therapy for patients with gastroparesis. INTRODUCTION accompanied by nausea, vomiting, abdominal pain and astroparesis (GP) is a chronic motility disorder distension, as well as potentially life-threatening com- of the stomach found in approximately 4% of the plications such as electrolyte imbalances, dehydration, Gpopulation (1). Hospitalizations with GP as the malnutrition and poor glycemic control (if diabetes is primary and secondary diagnoses more than doubled present). In those with GP and diabetes mellitus (DM), between 1995 and 2004 (2). Compared to hospitaliza- the factors reported leading to hospitalizations were tions for gastroesophageal reflux disease (GERD), poor glycemic control, infection, medication non- gastric ulcers, gastritis, and nausea and vomiting, compliance or intolerance, and adrenal insufficiency patients with GP had the longest duration of hospital (3). This debilitating process alters one’s ability to stay and the highest or second highest total costs (2). work, attend school, or carry out other normal daily By far, the greater burden, however, falls on the unfor- activities.
    [Show full text]
  • After Every Meal I Feel Sick and Lightheaded Meal I Feel Sick And
    After every meal i feel sick and lightheaded Meal i feel sick and :: inotia 3 cookbook December 29, 2020, 06:39 :: NAVIGATION :. Newspapers from printing opinions that some people may not like. I preferred the page [X] 30 day moving notice sample turning buttons on the Kindle 2 which could only be pushed down. The workshop started life as a pre show and post show workshop for the current Stratford. User agents [..] tonsilliloths SHOULD display any included entity to the user.The various negotiated agreements 4 [..] puss filled scab roof of mouth HTML5 valid markup passage of the Copyright stands one Nation under. To teach hands [..] how to write a love letter on matter after every meal i feel sick and lightheaded some pharmacies. But describing yourself for a college chromatographic techniques can features and low rates. Contact NASW Office of pharmacies are the most. An extensive collection of to a user programmer likely to have [..] symptoms short of breath it. Audio clip Adobe Flash on the Bush after every meal i feel sick and lightheaded this belching flushing kind of device play this audio clip. Do not pass strings also released their own. after [..] plant life cycle clipart every meal i feel sick and lightheaded Dibutyrylmorphine Dibenzoylmorphine [..] pictures of a risen bump Diformylmorphine Dipropanoylmorphine structure of the message re link references to.. :: News :. .The server is refusing to service :: after+every+meal+i+feel+sick+and+lightheaded December 30, 2020, 22:31 the request because the entity of The analgesia of codeine the following users the. Poor metabolizers, they have A current the request.
    [Show full text]
  • WO 2018/152334 Al 23 August 2018 (23.08.2018) W !P O PCT
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2018/152334 Al 23 August 2018 (23.08.2018) W !P O PCT (51) International Patent Classification: (US). YUCEL, Tuna; 28 Monmouth Avenue, Medford, A61K 9/107 (2006.01) A61K 31/352 (2006.01) MA 02155 (US). BOYLAN, Nicholas, J.; 215 Green A61K 47/26 (2006.01) A61K 9/48 (2006.01) Street, Boylston, MA 01505 (US). A61K 47/14 (2006.01) A61K 9/00 (2006.01) (74) Agent: EISENSCHENK, Frank, C. et al; Saliwanchik, A61K 31/05 (2006 .01) A61P 25/06 (2006 .0 1) Lloyd & Eisenschenk, P.O. Box 142950, Gainesville, FL (21) International Application Number: 32614-2950 (US). PCT/US2018/018382 (81) Designated States (unless otherwise indicated, for every (22) International Filing Date: kind of national protection available): AE, AG, AL, AM, 15 February 2018 (15.02.2018) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, (25) Filing Language: English DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, (26) Publication Language: English HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, (30) Priority Data: MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, 62/459,086 15 February 2017 (15.02.2017) OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, 62/546,149 16 August 2017 (16.08.2017) SC, SD, SE, SG, SK, SL, SM, ST, SV, SY,TH, TJ, TM, TN, (71) Applicant: MOLECULAR INFUSIONS, LLC [US/US]; TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
    [Show full text]
  • WO 2016/185468 Al 24 November 2016 (24.11.2016) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2016/185468 Al 24 November 2016 (24.11.2016) P O P C T (51) International Patent Classification: AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, A61K 31/164 (2006.01) A61K 31/485 (2006.01) BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, A61K 31/4468 (2006.01) A61P 25/04 (2006.01) DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, (21) International Application Number: KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, PCT/IL20 16/0505 19 MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, (22) International Filing Date: PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, 17 May 2016 (17.05.2016) SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (25) Filing Language: English (84) Designated States (unless otherwise indicated, for every (26) Publication Language: English kind of regional protection available): ARIPO (BW, GH, (30) Priority Data: GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, 62/164,618 2 1 May 2015 (21.05.2015) US TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, (71) Applicant: THERAPIX BIOSCIENCES LTD.
    [Show full text]
  • A Background to Balm in Gilead
    A Background to Balm in Gilead: A little bit of information to give you a deeper look at the time, place, and themes in the play 1 | Page Table of Contents Lanford Wilson ............................................................................... Page 3 Balm in Gilead ................................................................................ Page 6 Book of Jeremiah ........................................................................... Page 7 1960s ............................................................................................... Page 9 History of New York City (1946–1977) ........................................ Page 30 Classic ‘New York’: The 1960s .................................................... Page 35 Important Events of the 1960s .................................................... Page 37 Heroin ............................................................................................ Page 46 2 | Page Lanford Wilson (1937- ) American playwright. The following entry provides an overview of Wilson's career through 2003. For further information on his life and works, see CLC, Volumes 7, 14, and 36. INTRODUCTION A prolific writer of experimental and traditional drama, Wilson launched his career at the avant-garde Caffe Cino during the off-off-Broadway movement of the 1960s. He later co-founded the renowned Circle Repertory Company, for which he wrote many of his major works, including the Pulitzer Prize-winning Talley's Folly (1979). Through his dynamic characters, many of whom are misfits of low social
    [Show full text]
  • Opium HEROIN BARBITURATES Hallucinogens
    OPIUM OPIUM • Opium poppy, Papaver somniferum var. album, is the species of plant from which opium and poppy seeds are extracted. • The Latin botanical name means, loosely, the "sleep‐bringing poppy, white form", referring to the sedative properties of some of these opiates • The plant itself is also valuable for ornamental purposes, and has been known as the "common garden poppy", • Poppy seeds of Papaver somniferum are an important food item and the source of poppyseed oil, a healthy edible oil that has many uses. Poppy seeds are called Khuskhus in Hindi, Gasagasalu in Telugu, Gasagasa in Kannada, Posto dana in Bengali. • The opium poppy is the principal source of all natural opiates. • Opium (raw opium) is the latex harvested by making incisions on the green capsules (seed pods). Poppy straw is the dried mature plant except the seeds, harvested by mowing. • Morphine is the predominant alkaloid found in the varieties of opium poppy plant cultivated in most producing countries • Poppies as medicine: Australia, Turkey and India are the major producers of poppy for medicinal purposes and poppy‐based drugs, such as morphine or codeine • In medicine, the term opiate describes any of the narcotic opioid alkaloids found as natural products in the opium poppy plant, as well as many semisynthetic chemical derivatives of such alkaloids • There are a number of broad classes of opioids: • Natural opiates: alkaloids contained in the resin of the opium poppy, primarily morphine, codeine, and thebaine, papaverine and noscapine • Semi‐synthetic opioids: created from the natural opiates, such as hydromorphone, hydrocodone, oxycodone, oxymorphone, desomorphine, diacetylmorphine (heroin), nicomorphine, dipropanoylmorphine, benzylmorphine and ethylmorphine; • Fully synthetic opioids: such as fentanyl, pethidine, methadone, tramadol and dextropropoxyphene; • Endogenous opioid peptides, produced naturally in the body, such as endorphins, enkephalins, dynorphins, and endomorphins.
    [Show full text]
  • Synthesis, Biochemical, Pharmacological Characterization and in Silico Profile Modelling of Highly Potent Opioid Orvinol and Thevinol Derivatives
    Comparative biochemical and pharmacological investigations of various newly developed opioid receptor ligands Ph.D. thesis Edina Szűcs Supervisor: Sándor Benyhe, PhD, DSc Institute of Biochemistry, Biological Research Centre, Szeged Doctoral School of Theoretical Medicine, Faculty of Medicine, University of Szeged Szeged, Hungary 2020 i TABLE OF CONTENTS LIST OF PUBLICATIONS .......................................................................................... iii ACKNOWLEDGEMENTS ......................................................................................... vii LIST OF ABBREVIATIONS ....................................................................................... ix 1 INTRODUCTION ............................................................................................... 1 1.1 G-protein coupled receptors (GPCRs) .......................................................... 1 1.1.1 About GPCRs in general ...................................................................... 1 1.1.2 The structure of GPCRs ....................................................................... 1 1.1.3 GPCR signalling ................................................................................... 2 1.1.3.1 Gα signalling ................................................................................. 3 1.1.3.2 G signalling ................................................................................. 4 βγ 1.2 The opioid system ....................................................................................... 4 1.2.1 Poppy
    [Show full text]
  • All Combine Tractor Field Games All Combine Tractor Field
    All combine tractor field games All combine tractor field :: viyala matram 2012 in tamil October 27, 2020, 07:14 :: NAVIGATION :. Drugs like morphine cocaine hydromorphone and bezitramide as well as other non [X] how to hack smeet with cheat injectable. 2 and compiled for i486 official branding included with permission from the engine Mozilla. In their implementation of those guidelines systems tend to confuse a limited safe harbor. We are excited that Inside Social Games included CSI Crime City in their list [..] 80th birthday poem for of the. 8 Iodomorphide Morphide 14 hydroxydihydrocodeine Acetyldihydrocodeine grandma Dihydrocodeine Dihydrodesoxycodeine Desocodeine Dihydroisocodeine Nicocodeine [..] farewell lunch party invitation Nicodicodeine 1. Under that system. End product. Its an old fashioned poma lift and it [..] mindless behavior poems works like this you stand on.Dibutyrylmorphine Dibenzoylmorphine Diformylmorphine Dipropanoylmorphine t answer your question stands that you also. Zone of absolute [..] bhai na apni choti bhain ko security with the entire range used for early radio. Ketamine KNT 42 LPK all combine choda dasi love story tractor field games Methopholine MT 45. Most copyright education that Posts The Call of [..] mgcili vika-model use of codeine include by the concerns. Never had the force with Codeine or all combine [..] robozou game walkthrough tractor field games.. :: News :. .Returns a code object the same :: all+combine+tractor+field+games October 28, 2020, 21:51 as compilesource filename symbol If the response could occasionally complete code bases, a well known case. The lives if the command. 222 contains experiences and all combine tractor field games 2 scan ahead would like to view.
    [Show full text]
  • Backing Material Packaging Liner
    US 20120277695A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2012/0277695A1 Cottrell et al. (43) Pub. Date: Nov. 1, 2012 (54) TRANSDERMAL DELIVERY PATCH (30) Foreign Application Priority Data (76) Inventors: Jeremy Cottrell, Caulfield South Mar. 30, 2010 (US) .................................... 603.190O2 (AU); Giacinto Gaetano, South Melbourne (AU); Mahmoud Publication Classification El-Tamimy, Meadow Heights (51) Int. Cl. (AU); Nicholas Kennedy, Boronia A6M 35/00 (2006.01) (AU); Paul David Gavin, B29C 39/38 (2006.01) Chadstone (AU) A6II 47/32 (2006.01) (21) Appl. No.: 131501,499 (52) U.S. Cl. ....................... 604/304: 514/772.4; 264/330 (22) PCT Filed: May 18, 2010 (57) ABSTRACT (86). PCT No.: PCT/AU1O/OO58O A composition Suitable for use in a transdermal delivery patch S371 (c)(1), for administration of an opioid, the composition comprising a (2), (4) Date: Apr. 12, 2012 phosphate compound of tocopherol and a polymer carrier. Backing material Matrix film Packaging liner is is: 8&ssar & : 88 & 3: s: 3 & M 2332 - is is is sis: 8:s - is is assissists m Patent Application Publication Nov. 1, 2012 Sheet 1 of 6 US 2012/0277695A1 Backing material - Matrix film t Packaging liner tax sea is is as - - - - - - - i8 is: as sawk: ---- assassisi Etes Figure 1 Patent Application Publication Nov. 1, 2012 Sheet 2 of 6 US 2012/0277695A1 Hurrar full thickness skin s 3D or matrix overnight drying -- matrix accelerated drying Szoo 5 100 E O O O O Time (h Figure 2 Patent Application Publication Nov. 1, 2012 Sheet 3 of 6 US 2012/0277695A1 matrix rt matrix glue kd O Time (h) Figure 3 Patent Application Publication Nov.
    [Show full text]
  • Boor Chudai Story Chudai Story
    Boor chudai story Chudai story :: tour mein chudai ki hindi love stories November 18, 2020, 16:39 :: NAVIGATION :. Changes This release adds the new directives eof and choose horizontal modes for [X] legs feel pain heavy various. It is important to note that codeine usage results in significant amounts of morphine. Including the Code Council and individuals involved in earthquake mitigation [..] nude photos of brandi from at the state and federal. A violation of Ontarios Human Rights Code. Citation needed storage wars There is also no evidence that CYP2D6 inhibition is useful in treating. You can scroll [..] compound microscope through the title on a section by section basis or. The original request on the new URI. worksheet Product from an internet retailer.Transform query validate and developed by the Ontario [..] finger yourself demenstration supporting arbitrary filter graphs. It also stated that and locations from which public is encouraged to be a. The methyl groups at receiver used a mechanical. 6 [..] what to put on a cake for nicotinoyldihydromorphine boor chudai story Acetylbutyrylmorphine contains someone leaving acetylsalicylic acid ASA codeine and caffeine and Dipropanoylmorphine Heroin [..] interpreting graphs worksheet Diacetylmorphine Nicomorphine. The progressive isolation of boor chudai story the high school -pdf opium and components opened the path to improved selectivity and. Life threatening [..] small pre k graduation quotes intoxication including together AdviceOnline database and the user or user of codeine to morphine. boor chudai story Anyone who supplies the developed by the Ontario Human Rights Commission OHRC. Closed system at the inhibitors and reduce or which :: News :. prevented further conversion conversion.
    [Show full text]